News tagged with oncology
Related topics: cancer , chemotherapy , breast cancer , radiation oncology , journal of clinical oncology
Docetaxel significantly increases survival for incurable gastric cancers
Survival for advanced stomach and oesophagael cancer patients increases by 40 per cent when treated with the chemotherapy drug, Docetaxel – providing evidence to prescribe it as a second-line treatment, ...
Cancer
Jan 23, 2013 |
5 / 5 (1) |
0
Study shows drug combination extends pancreatic cancer patient survival
A multi-center Phase III clinical trial demonstrates that Abraxane (nab-paclitaxel) plus gemcitabine is the first combination of cancer drugs to extend survival of late-stage pancreatic cancer patients compared to standard ...
Cancer
Jan 22, 2013 |
5 / 5 (1) |
0
New drug protects against side effects of chemotherapy
A drug developed at Linköping University in Sweden protects against the side effects of cancer treatments while strengthening the effects on the tumour. An international drug evaluation is now starting up on a larger group ...
Cancer
Jan 22, 2013 |
not rated yet |
0
Palliative radiation use for lung cancer higher than advised
(HealthDay)—Half of patients with metastatic non-small-cell lung cancer (NSCLC) receive at least one course of palliative radiation therapy (RT), with younger patients and those who received chemotherapy ...
Cancer
Jan 18, 2013 |
not rated yet |
0
Expression, genomic patterns predict sarcoma progression
(HealthDay)—The Complexity Index in Sarcoma (CINSARC) and Genomic Index prognostic signatures are valid independent methods of assessing synovial sarcoma (SS) prognosis, according to a study published online ...
Cancer
Jan 18, 2013 |
not rated yet |
0
Tricuspid regurgitant jet velocity up in childhood cancer survivors
(HealthDay)—About one-quarter of adult survivors of childhood cancer who received chest-directed radiation therapy (RT) have increased tricuspid regurgitant jet velocity (TRV), according to research published ...
Cancer
Jan 18, 2013 |
not rated yet |
0
Income affects oncology clinical trial participation
(HealthDay)—Oncology patients with lower income, even older patients with access to Medicare, are significantly less likely to participate in clinical trials, according to research published online Jan. ...
Cancer
Jan 16, 2013 |
not rated yet |
0
Surgery doesn't up pediatric neuroblastoma outcomes
(HealthDay)—For pediatric patients with stage 4 neuroblastoma, surgery of the primary tumor site has no impact on outcomes, according to a study published online Jan. 2 in the Journal of Clinical Oncology.
Cancer
Jan 15, 2013 |
not rated yet |
0
Alkylating agent linked to therapy-related leukemia
(HealthDay)—For patients treated for Hodgkin's lymphoma (HL), cumulative doses of alkylating agent (AA) is associated with the risk of therapy-related acute myeloid leukemia/myelodysplastic syndrome (t-AML/MDS), ...
Cancer
Jan 15, 2013 |
5 / 5 (1) |
0
ASCO issues guideline for febrile neutropenia in adults
(HealthDay)—The American Society of Clinical Oncology has issued updated recommendations for both the prevention and management of febrile episodes in neutropenic oncology outpatients; the recommendations ...
Cancer
Jan 15, 2013 |
not rated yet |
0
Comparable patterns of failure between SBRT, lobectomy or pneumonectomy for stage I NSCLC
For patients with medically operable clinical stage I non–small-cell lung cancer (NSCLC), lobectomy or pneumonectomy is the standard approach. For patients with medically inoperable stage I NSCLC, stereotactic body radiotherapy ...
Cancer
Jan 15, 2013 |
not rated yet |
0
EGFR mutation not prognostic factor in non-small cell lung cancer
Recent studies have demonstrated that molecular-targeted agents, such as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI), may prolong survival of selected patients based on tumor biomarkers. The presence ...
Cancer
Jan 15, 2013 |
not rated yet |
0
Patients with EGFR exon 20 insertions have poorer prognosis
Exon 20 insertions are the third most common family of epidermal growth factor receptor (EGFR) mutations found in non–small-cell lung cancer (NSCLC). Little is known about cancers harboring these mutations aside from their ...
Cancer
Jan 15, 2013 |
not rated yet |
0
Scientists find a new way to boost common cancer drugs
Shutting down a specific pathway in cancer cells appears to improve the ability of common drugs to wipe those cells out, according to new research from scientists at Fox Chase Cancer Center, published in the January issue ...
Cancer
Jan 14, 2013 |
5 / 5 (2) |
0
|
In oropharyngeal cancer, HPV status impacts distant mets risk
(HealthDay)—In patients with oropharyngeal cancer (OPC), human papillomavirus (HPV) status and T and N staging categories affect the rate of distant control (DC) and may help identify candidates for treatment ...
Cancer
Jan 14, 2013 |
not rated yet |
0
